Skip to main content

Dr. Michael J. Smith, MD

Pediatric Infectious Disease (Pediatric Infectious Diseases Physician)

At a glance

In the NPI registry since
2007

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Pediatric Infectious Diseases Physician primary
    KY license 41086
  • Pediatrics Physician
    KY license 41086

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Pediatric Infectious Disease per capita by county →

Payments from drug and device companies

In 2025, 1 companies reported 9 payments worth $1,721 in total to this clinician.

By company
Merck Sharp & Dohme LLC$1,721
By type
Travel and Lodging$1,392
Food and Beverage$330

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Oct 8, 2025Merck Sharp & Dohme LLC
Oct 8, 2025
Travel and Lodging
PREVYMIS · INFECTIOUS DISEASE · travel to Philadelphia, PA · in-kind
Company’s descriptionProvided as part of a clinical research engagement.
$700
Oct 8, 2025Merck Sharp & Dohme LLC
Oct 8, 2025
Travel and Lodging
PREVYMIS · INFECTIOUS DISEASE · travel to Philadelphia, PA · in-kind
Company’s descriptionProvided as part of a clinical research engagement.
$283
Oct 8, 2025Merck Sharp & Dohme LLC
Oct 8, 2025
Travel and Lodging
PREVYMIS · INFECTIOUS DISEASE · travel to Philadelphia, PA · in-kind
Company’s descriptionProvided as part of a clinical research engagement.
$162
Oct 8, 2025Merck Sharp & Dohme LLC
Oct 8, 2025
Travel and Lodging
PREVYMIS · INFECTIOUS DISEASE · travel to Philadelphia, PA · in-kind
Company’s descriptionProvided as part of a clinical research engagement.
$142
Oct 29, 2025Merck Sharp & Dohme LLC
Oct 29, 2025
Travel and Lodging
PREVYMIS · INFECTIOUS DISEASE · travel to Philadelphia, PA
Company’s descriptionProvided as part of a clinical research engagement.
$106

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Kentucky →

Industry-funded research

Named as a principal investigator on 4 industry-funded studies in 2025, from 2 companies. The companies reported $574,240 in research payments for these studies, mostly to the institutions running them.

  • A phase 2 randomized doubleblind trial to evaluate the safety tolerability and immunogenicity of a multivalent pneumococcal conjugate vaccine in healthy infants
    Pfizer Inc.
  • A Phase 1, Open-label, Single-arm Study to Evaluate the Pharmacokinetics and Safety of Letermovir in Pediatric Kidney Transplant KT Recipients Less Than 18 Years of Age and Weighing Less Than 40 Kilograms
    Merck Sharp & Dohme LLC
  • A phase 2 randomized partially doubleblind trial to evaluate the safety tolerability and immunogenicity of a multivalent pneumococcal conjugate vaccine administered in healthy toddlers 12 through 15 months of age
    Pfizer Inc.
  • A phase 1 randomized doubleblind sponsoropen study to describe the safety and tolerability of a multivalent pneumococcal conjugate vaccine in adults
    Pfizer Inc.

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Pediatric Infectious Disease clinicians in Louisville

Sources

NPI registry (CMS NPPES, November 2026; record last updated September 4, 2014), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1336340454. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.